NKGen Biotech, Inc. Common Stock (NKGN) is a biotechnology company listed on US.
Latest reported NKGN revenue for 2023-12-31 was $0. Net income was -$83.0M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. NKGN currently screens at market cap $22.4M.
Use this NKGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NKGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NKGN SEC filings page. Lician reads the product cache first so this HTML stays unique to NKGen Biotech, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full NKGN income, balance, and cash tables.